{
  "txid": "f1b9f79ab7301ca60232004e2dc2bf2c66ce61294e58dc4761992764796d89e6",
  "block_height": 0,
  "time": null,
  "app": "treechat",
  "type": "post",
  "map_content": "The Ethical Role of the Pharmacist\r\nThe Conflict of Interest Between Sales and the Rational Use of Medicines\r\nA medicine is not an ordinary commodity. Although it operates within the market and is traded as an economic good, its nature is fundamentally healthcare-related. It has the power to relieve and cure, but also to cause harm when used inappropriately. At this delicate intersection\u2014where benefit and risk coexist\u2014stands the pharmacist, not as a mere commercial intermediary, but as a healthcare professional with direct ethical responsibility towards both the patient and society.\r\nYet the contemporary pharmacy model, particularly when shaped by retail-driven logics, creates a structural conflict of interest: the pressure to sell more versus the professional duty to promote the rational, safe and responsible use of medicines. This conflict is neither anecdotal nor marginal; it is systemic.\r\nMedicines: more than consumer goods\r\nUnlike most tradable goods, medicines act upon complex biological processes and may cause serious adverse effects, dependence, antimicrobial resistance and cumulative harm. Their misuse affects not only the individual patient but also the wider community. Treating medicines as ordinary consumer products is therefore not a harmless simplification; it is a dangerous distortion.\r\nAccess to medicines must be mediated by technical knowledge, clinical judgement and professional responsibility. When this mediation is subordinated to commercial incentives, risk is silently transferred to the patient.\r\nConflict of interest in daily practice\r\nWhen pharmacies are managed primarily according to commercial objectives, pharmacists are exposed to constant pressures: sales targets, product-based incentives, turnover expectations and margin optimisation. In such an environment, practices such as promoting unnecessary medicines, substituting products based on profitability, or normalising self-medication cease to be exceptions and become routine.\r\nThis is not a rejection of the market itself, but a recognition that healthcare cannot tolerate perverse incentives. A system that rewards sales volume over clinical judgement ultimately erodes the pharmacy\u2019s public health function.\r\nRational use of medicines as an ethical duty\r\nThe World Health Organization defines rational use of medicines as a situation in which patients receive the appropriate medicine, in the correct dose, for an adequate period of time, and at the lowest possible cost to themselves and society. This principle, frequently cited, is often insufficiently understood in its ethical dimension.\r\nPromoting rational use frequently means selling less. It requires warning, educating, correcting and, at times, refusing to dispense when it is not clinically appropriate. It demands professional independence and ethical conviction, even when these conflict with immediate commercial interests.\r\nMarket freedom and professional responsibility\r\nFrom a liberal or libertarian perspective, the market is a powerful mechanism for allocating resources. However, economic freedom does not eliminate information asymmetry, nor does it replace professional ethics\u2014particularly in healthcare. Patients are not fully informed consumers operating on equal footing; they place legitimate trust in the pharmacist\u2019s expertise.\r\nA genuinely functional market requires clear rules and responsible professionals. Freedom without responsibility is not freedom; it is institutionalised negligence.\r\nProfessional pharmaceutical leadership as a minimum condition\r\nAllowing pharmacies to be controlled by interests external to the pharmaceutical profession weakens their healthcare role. This is not an argument for statisation or against profit per se, but a recognition that the dispensing of medicines requires clinical judgement with real decision-making authority, not a symbolic signature within a commercial hierarchy.\r\nWhen pharmacists truly direct and assume responsibility for the pharmacy, the conflict of interest does not disappear, but it is managed through professional accountability rather than concealed behind sales metrics.\r\nConclusion\r\nThe conflict between the sale of medicines and their rational use is not an individual failing but a structural problem. Ignoring it may be convenient; confronting it is an ethical obligation.\r\nThe pharmacist\u2019s role is not to maximise sales, but to minimise harm and maximise therapeutic benefit. Defending the rational use of medicines is not an ideological stance against the market, but a defence of public health, patient safety and the dignity of the pharmaceutical profession.",
  "media_type": "text/markdown",
  "filename": "|",
  "author": "14aqJ2hMtENYJVCJaekcrqi12fiZJzoWGK",
  "display_name": "alexrivasm\ud83c\udf00",
  "channel": null,
  "parent_txid": null,
  "ref_txid": null,
  "tags": null,
  "reply_count": 0,
  "like_count": 0,
  "timestamp": "2025-12-26T07:29:29.000Z",
  "media_url": null,
  "aip_verified": true,
  "has_access": true,
  "attachments": [],
  "ui_name": "alexrivasm\ud83c\udf00",
  "ui_display_name": "alexrivasm\ud83c\udf00",
  "ui_handle": "alexrivasm\ud83c\udf00",
  "ui_display_raw": "alexrivasm\ud83c\udf00",
  "ui_signer": "14aqJ2hMtENYJVCJaekcrqi12fiZJzoWGK",
  "ref_ui_name": "unknown",
  "ref_ui_signer": "unknown"
}